Mineralys Therapeutics’ lorundrostat targets nocturnal hypertension linked to sleep apnea.| Sleep Review
By attending this webinar, you will be able to: evaluate and optimize CPAP therapy parameters; better identify comorbid sleep disorders in treated OSA patients; and list adjunctive therapies to consider.| Sleep Review